Home The Word Brain My Amedeo FAQ Privacy About   


Hanzi Hunter — ultra-fast Hanzi study

All 1,152 characters from the aioLingua manual

AbstractAboutThe 20 audio files

← aioLingua Chinese Online

← Chinese aioLingua PDF


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Dig Dis

Retrieve available abstracts of 27 articles:
HTML format



Single Articles


    October 2025
  1. MEIR Y, Leibovitzh H, Shaham D, Hirsch A, et al
    Effectiveness of the Crohn's Disease Exclusion Diet for the Treatment of Crohn's Disease in the Older-Adult Population: Real-World Experience.
    Dig Dis. 2025 Oct 20:1-21. doi: 10.1159/000548931.
    PubMed     Abstract available


  2. DOUKAS PG, Doukas SG, Broder A
    Effectiveness and Safety of Fecal Microbiota Transplantation for Ulcerative Colitis Treatment: A Systematic Review and Meta-Analysis.
    Dig Dis. 2025 Oct 10:1-22. doi: 10.1159/000548568.
    PubMed     Abstract available


    August 2025
  3. REGUEIRO M, Gulati T, Bandyopadhyay A, Fisher DA, et al
    Real-world Dose Escalation and Associated Direct Costs of Biologics in Management of Ulcerative Colitis: A Retrospective Database Study.
    Dig Dis. 2025 Aug 16:1-16. doi: 10.1159/000547994.
    PubMed     Abstract available


  4. FERREIRA AI, Capela TL, Xavier S, Arieira C, et al
    Tailoring Crohn's disease surveillance in clinical remission: new insights from the Lewis score.
    Dig Dis. 2025 Aug 4:1-19. doi: 10.1159/000546541.
    PubMed     Abstract available


    June 2025
  5. HAYASAKA J, Matsui A, Kikuchi D, Hoteya S, et al
    Impact of therapeutic agents on serum leucine-rich alpha-2 glycoprotein for monitoring endoscopically remitted ulcerative colitis.
    Dig Dis. 2025 Jun 24:1-22. doi: 10.1159/000547007.
    PubMed     Abstract available


    May 2025
  6. SARBAGILI-SHABAT C, Zelber-Sagi S, Fliss Isakov N, Hirsch A, et al
    High ultra-processed food consumption is associated with clinical exacerbation in patients with Crohn's disease in remission - a prospective cohort study.
    Dig Dis. 2025 May 20:1-17. doi: 10.1159/000546486.
    PubMed     Abstract available


    February 2025
  7. DE GREEF I, Bislenghi G, Terrasson I, Sabino J, et al
    No increased risk of venous thromboembolism or infectious complications after JAK inhibitor exposure in patients with ulcerative colitis undergoing surgery.
    Dig Dis. 2025 Feb 27:1-21. doi: 10.1159/000544062.
    PubMed     Abstract available


  8. ZHANG H, Xiang J, Feng J, Zhang M, et al
    Gut microbiome dysbiosis and inflammatory bowel disease complement each other.
    Dig Dis. 2025 Feb 25:1-18. doi: 10.1159/000544771.
    PubMed     Abstract available


    November 2024
  9. CLASSEN JM, Muzalyova A, Rommele C, Nagl S, et al
    Antibody response to SARS-CoV2 before and after the third vaccination in patients with Inflammatory Bowel Disease.
    Dig Dis. 2024 Nov 30:1-19. doi: 10.1159/000542353.
    PubMed     Abstract available


  10. ZHANG Q, Lou D, Zhang Y, Xu A, et al
    A Meta-Analysis of Proton Pump Inhibitor Exposure and the Risk of Adverse Outcomes in Patients with Inflammatory Bowel Disease.
    Dig Dis. 2024 Nov 21:1-16. doi: 10.1159/000542729.
    PubMed     Abstract available


  11. MATTILA J, Kallio J, Loyttyniemi E, Nuutila P, et al
    Combined [18F]-FDG PET-MR Imaging: A promising tool for diagnostics of small bowel Crohn's disease.
    Dig Dis. 2024 Nov 13:1-23. doi: 10.1159/000542379.
    PubMed     Abstract available


    October 2024
  12. MATSUMOTO S, Mashima H
    Clinical profiles of leucine-rich alpha-2 glycoprotein for indicating mucosal healing in ulcerative colitis patients under administration of molecular targeted drug.
    Dig Dis. 2024 Oct 25:1-18. doi: 10.1159/000542062.
    PubMed     Abstract available


    August 2024
  13. GINARD D, Barreiro-de Acosta M, Nos P, Moraleja I, et al
    Efficacy of beclomethasone dipropionate in lowering fecal calprotectin levels in patients with ulcerative colitis in clinical remission and at risk of relapse: The Becalcu randomized, controlled trial.
    Dig Dis. 2024 Aug 22. doi: 10.1159/000540792.
    PubMed     Abstract available


    May 2024
  14. CAPPUCCIO JM, Mehta N, Pellish R
    Inpatient Infliximab Biosimilar Cost-Savings - Cost analysis of inpatient treatment with originator Infliximab (Remicade) vs biosimilar Infliximab (Renflexis) for acute severe ulcerative colitis.?.
    Dig Dis. 2024 May 24. doi: 10.1159/000536303.
    PubMed     Abstract available


    March 2024
  15. GUERRA I, Barros F, Chaparro M, Benitez JM, et al
    Evaluation of genetic variants associated with the risk of thiopurine-related pancreatitis: a case control study from ENEIDA registry.
    Dig Dis. 2024 Mar 7. doi: 10.1159/000537782.
    PubMed     Abstract available


    January 2024
  16. SOKIC-MILUTINOVIC A, Milosavljevic T
    Inflammatory Bowel Disease: From Conventional Immunosuppression to Biologic Therapy.
    Dig Dis. 2024;42:325-335.
    PubMed     Abstract available


    December 2023
  17. SIGALL BONEH R, Assa A, Lev-Tzion R, Matar M, et al
    Adherence to the Mediterranean diet is associated with decreased Fecal Calprotectin Levels in Children with Crohn's Disease in Clinical Remission under biological Therapy.
    Dig Dis. 2023 Dec 1. doi: 10.1159/000535540.
    PubMed     Abstract available


    September 2023
  18. YANG MM, Usiskin K, Ahmad HA, Ather S, et al
    Considerations for Colorectal Neoplasia Detection in Inflammatory Bowel Disease Clinical Trials.
    Dig Dis. 2023 Sep 27. doi: 10.1159/000533395.
    PubMed     Abstract available


  19. BOLDOVJAKOVA D, El-Abbassy I, Alarcon I, El-Saify M, et al
    Management of the Rectal Stump after Subtotal Colectomy Operations for Inflammatory Bowel Disease in the Era of Immunologic Therapy: A Two-Centre Cohort Study.
    Dig Dis. 2023 Sep 8:1-7. doi: 10.1159/000533267.
    PubMed     Abstract available


    August 2023
  20. BASTIDA PAZ G, Merino Ochoa O, Aguas Peris M, Barreiro-de Acosta M, et al
    The Risk of Developing Disabling Crohn's Disease: Validation of a Clinical Prediction Rule to Improve Treatment Decision Making.
    Dig Dis. 2023 Aug 23:1-11. doi: 10.1159/000531789.
    PubMed     Abstract available


    June 2023
  21. NERI B, Russo C, Mossa M, Martire FG, et al
    High Frequency of Deep Infiltrating Endometriosis in Patients with Inflammatory Bowel Disease: A Nested Case-Control Study.
    Dig Dis. 2023 Jun 30:1. doi: 10.1159/000530896.
    PubMed     Abstract available


  22. SURDEA-BLAGA T, Ismaiel A, Jaaouani A, Leucuta DC, et al
    Adiponectin Levels in Inflammatory Bowel Disease - A Systematic Review and Meta-analysis.
    Dig Dis. 2023 Jun 29. doi: 10.1159/000531614.
    PubMed     Abstract available


  23. SHI H, Zeng H, Wang M, Jiang J, et al
    Effectiveness of water-assisted colonoscopy without sedation in patients with ulcerative colitis.
    Dig Dis. 2023 Jun 27. doi: 10.1159/000531652.
    PubMed     Abstract available


    March 2023
  24. SALEH A, Parsa S, Garza M, Quigley EMM, et al
    The Role of Fecal Microbiota Transplantation in the Induction of Remission in Ulcerative Colitis.
    Dig Dis. 2023 Mar 1. doi: 10.1159/000529591.
    PubMed     Abstract available


    January 2023
  25. HELWIG U, Krause TH, Maaser C, Buning J, et al
    Early MOnitoring of REsponse (MORE) to Golimumab Therapy: Results of a Multicentre, Prospective Observational Trial.
    Dig Dis. 2023;41:239-249.
    PubMed     Abstract available


  26. PELEG N, Yanai H, Gingold-Belfer R, Dotan I, et al
    Video Capsule Endoscopy after Bariatric Surgery: A Tertiary Referral Center Experience.
    Dig Dis. 2023;41:233-238.
    PubMed     Abstract available


  27. KRAL J, Nakov R, Lanska V, Barberio B, et al
    Significant Differences in IBD Care and Education across Europe: Results of the Pan-European VIPER Survey.
    Dig Dis. 2023;41:387-395.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.